An investor asked a question on the investor interaction platform: in addition to riboflavin and other raw materials, your company also produces other drugs, such as bantolavo sodium enteric coated tablets and lafutidine granules, which can inhibit gastric cancer caused by Helicobacter pylori. Your company has produced them. Today, human beings pay more and more attention to health, Do you have any grand plans for the development of such drugs? thank you.
Hubei Guangji Pharmaceutical Co.Ltd(000952) (000952. SZ) said on the investor interaction platform on January 7 that the company would increase the investment in the consistency evaluation of relevant products. At present, tinidazole tablets have entered the market through the consistency evaluation.
(source: Daily Economic News)
